A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH. Francque SM, Bedossa P, Ratziu V, Anstee QM, et al. N Engl J Med 2021;385:1547-1558.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Francque SM, Bedossa P, Ratziu V, Anstee QM, et al. A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH. N Engl J Med 2021;385:1547-1558.
PMID: 34670042